Abstract. Alzheimer's disease is a neurodegenerative disorder associated with aging and cognitive decline. Amyloid beta peptide (1-42) ] is a primary constituent of senile plaques-a hallmark of Alzheimer's disease-and has been implicated in the pathogenesis of the disease. Previous studies have shown that methionine residue 35 of Aβ(1-42) may play a critical role in Aβ(1-42)-mediated oxidative stress and neurotoxicity. Several additional mechanisms of neurotoxicity have been proposed, including the role of Cu(II) binding and reduction to produce hydrogen peroxide and the role of peptide aggregation. It has been reported that rodent Aβ is less likely to form larger β-sheet structures, and consequently, large aggregates. As a consequence of the lack of deposition of the peptide in rodent brain, rodent Aβ has been proposed to be non-toxic. Additionally, the sequence of the rodent variety of Aβ(1-42) contains three amino acid substitutions compared to the human sequence. These substitutions include the shift of arginine 5, trysosine 10, and histidine 13 to glycine, phenylalanine, and arginine, respectively. This shift in sequence within the Cu(II) binding region of the peptide results in a decrease in the ability of the rodent Aβ peptide to reduce Cu(II) to Cu(I) compared to the human Aβ peptide. As a result of the effect of the amino acid variations on the ability of the rodent peptide to reduce Cu(II) to Cu(I) compared to the human peptide, the rodent Aβ has been proposed to lack oxidative stress properties. In this study, the oxidative stress and neurotoxic properties of rodent Aβ(1-42) [Aβ(1-42)Rat] were evaluated and compared to those of human Aβ(1-42). Both human Aβ(1-42) and Aβ(1-42)Rat were found to have a significant effect on neuronal DNA fragmentation, loss of neuritic networks, and cell viability. Aβ(1-42) Rat was found to cause a significant increase in both protein oxidation and lipid peroxidation, similar to Aβ(1-42), both of which were inhibited by the lipid-soluble, chain breaking antioxidant vitamin E, suggesting that reactive oxygen species play a role in the Aβ-mediated toxicity. Taken together, these results suggest that Cu(II) reduction may not play a critical role in Aβ(1-42)Rat-induced oxidative stress, and that the oxidative stress exhibited by this peptide may be a consequence of the presence of methionine 35, similar to the findings associated with the native human Aβ(1-42) peptide.
Introduction
Amyloid beta peptide is a 39-43 amino acid long peptide which results from the proteolytic cleavage of amyloid β-protein precursor (AβPP) by β-and γ-secretase. Amyloid beta [Aβ ] is the primary constituent of senile plaques, a hallmark of Alzheimer's disease (AD). Alzheimer's disease is a neurodegenerative disorder associated with cognitive decline and aging. Aβ has been shown to induce protein oxidation and lipid peroxidation in vitro and in vivo [15, 51] . Both protein oxidation and lipid peroxidation have been found to be significantly increased in AD brain [8, 21, 46] . Consequently, Aβ has been proposed to play a central role in the pathogenesis of the disease as a mediator of oxidative stress and neurotoxicity [43] .
Several mechanisms of Aβ(1-42)-mediated oxidative stress and neurotoxicity have been proposed. Previous studies have shown that methionine residue 35 of Aβ may play a critical role in Aβ(1-42)-mediated oxidative stress and neurotoxicity [7, 11, 26, 39, 40, 42, 48, 51] . Additionally, it has been hypothesized that Cu(II) binding by histidine 6, 13, and 14 and reduction by an electron donated from tyrosine 10 may play a role in Aβ(1-42) toxicity [5, 13, 23, 24, 36] . Finally, the aggregation state of the peptide is believed to play a role in the oxidative stress and neurotoxic properties exhibited by Aβ [27, 32, 38, 45] .
Previously it has been reported that rodent amyloid beta peptide does not form fibrillar aggregate deposits in the brain. Additionally, it has been shown that rodent Aβ has less tendency to form β-sheet structures in vivo than human Aβ [16, 37] . Nevertheless, rodent and human Aβ peptides have been shown to possess similar solubility and in vitro fibril formation [20, 22] . The lack of β-sheet formation and fibrillar peptide aggregate deposits of Aβ in rodent brain is believed to be due to the differences in the primary amino acid sequence between human and rodent Aβ. Rodent Aβ(1-42) contains three amino acid variations of the human peptide sequence. Arginine 5, tyrosine 10, and histidine 13 are substituted by glycine, phenylalanine, and arginine, respectively [28] (Fig. 1) . Due to the amino acid mutations within the copper binding domain of the peptide, rodent Aβ has been shown to lack the ability to reduce Cu(I) and, as a result, has been presumed not to possess the same toxic properties of human Aβ .
In this study, we report the oxidative stress and neurotoxic properties of rodent Aβ [Aβ Rat] compared to human Aβ . Aβ(1-42)Rat induced protein carbonyl and 4-hydroxynonenal immunoreactivity in neurons similar to that of human Aβ(1-42), albeit to a lesser degree. These effects were inhibited by pretreatment with the lipid-soluble, chain breaking antioxidant vitamin E similar to the human peptide [50] , suggesting that reactive oxygen species play a role in the Aβ-mediated oxidative stress of both peptides.
Methods

Chemicals
All chemicals were of the highest purity and were obtained from Sigma (St. Louis, MO, USA) unless otherwise noted. Aβ(1-42)Rat was a generous gift of Dr. Ralph Martins (Perth, Australia). Additional Aβ(1-42)Rat was purchased from Bachem Bioscience (King of Prussia, PA). Aβ(1-42) was purchased from Anaspec (San Jose, CA, USA) with HPLC and MS verification of purity. The peptides were stored in the dry state at −20
• C until use. The OxyBlot protein oxidation detection kit was purchased from Chemicon International (Temecula, CA, USA). Anti-4-hydroxynonenal was purchased from Alpha Diagnostic International (San Antonio, TX, USA).
Cell culture experiments
Neuronal cultures were prepared from 18-day-old Sprauge-Dawely rat fetuses [52] . Aβ peptides were dissolved in sterile water that had been stirred over Chelex-100 resin. The peptides were preincubated for 24 hr at 37
• C prior to addition to cultures. The final concentration of the peptides in the cell culture was 10 µM, and the effects of Aβ on the neurons were measured after 24 hr of exposure.
Cell viability was evaluated by the 3-[4,5-dimethylthiazol-2-yl)-2,5-diphenyl] tetrazolium bromide (MTT) reduction assay. Briefly, MTT was added to each well with a final concentration of 1.0 mg/ml, and incubated for one hour. The dark blue formazan crystals formed in intact cells were extracted with 250 µl of dimethyl sulfoxide (DMSO), and the absorbance was read at 595 nm with a microtiter plate reader (Bio-Tek Instruments, Winooski, VT, USA).
Protein carbonyls
5 µl of sample was incubated for 20 minutes at room temperature with 5 µl of 12% sodium dodecyl sulfate (SDS) and 10 µl of 2,4-dinitrophenylhydrazine (DNPH) that was diluted 10 times with water from a 200 mM stock. The samples were neutralized with 7.5 µl of neutralization solution (2 M Tris in 30% glycerol). 250 ng of the resulting sample was loaded per well in the slot blot apparatus. Samples were loaded onto a nitrocellulose membrane under vacuum pressure. The membrane was blocked with 3% bovine serum albumin (BSA) in phosphate buffered saline 
4-Hydroxynonenal
10 µl of sample was incubated with 10 µl of modified Laemmli buffer containing 0.125 M Tris base pH 6.8, 4% (v/v) SDS, and 20% (v/v) glycerol. 250 ng of the resulting sample was loaded per well in the slot blot apparatus. Samples were loaded onto a nitrocellulose membrane under vacuum pressure. The membrane was blocked with 3% (w/v) BSA in wash blot for 1 hr and incubated with a 1:5000 dilution of anti-4-hydroxynonenal (HNE) polyclonal antibody in wash blot for 90 mins. Following completion of the primary antibody incubation, the membranes were washed three times in wash blot for five minutes each. An anti-rabbit IgG alkaline phosphatase secondary antibody was diluted 1:8000 in wash blot and added to the membrane for 90 mins. The membrane was washed in wash blot three times for five minutes and developed using Sigmafast Tablets (BCIP/NBT substrate). Blots were dried, scanned with Adobe Photoshop (San Jose, CA, USA), and quantitated with Scion Image.
Thioflavin T binding assay
The thioflavin T (ThT) binding assay was performed according to the method of LeVine [31] . A solution of 50 mM Glycine pH 8.5 containing 5 µM ThT was added to Aβ peptides incubated in solution for 24 hrs to a final peptide concentration of 2.5 µM, 5 µM, 7.5 µM, and 10 µM. The resulting fluorescence was measured with at λ ex = 440 nm and λ em = 485 nm with a SpectraMax GeminiXS (Molecular Devices, Sunnyvale, CA, USA).
Copper reduction
The ability of the Aβ peptides to reduce copper was measured by the BCA method described by Huang et al. [23] . Briefly, the peptides (10 µM), copper (II) (25 µM) , and the copper (I) indicator BCA (250 µM) were co-incubated in phosphate-buffered saline (PBS) pH 8.0 in a 96-well microtiter plate for 1 hr at 37
• C. Controls were conducted with ascorbate (10 µM) in place of the peptide. Absorbance was measured at λ = 562 nm (Bio-Tek Instruments, Winooski, VT, USA). The concentration of Cu(I) was calculated based on the known molar absorptivity (ε = 7700 M −1 cm −1 ).
Electron microscopy
Electron microscopy was used to assess the ability of the Aβ peptides to form fibrils upon incubation in solution for 24 hrs. Aliquots of 5 µl of the peptide solutions that were used for the cell culture experiments were placed on a copper mesh formvar carbon-coated grid. After 1-1.5 min of incubation at room temperature, excess liquid was drawn off, and samples were counterstained with 2% uranyl acetate. Air dried samples were examined in a Philips Tecnai Biotwin 12 transmission electron microscope (FEI, Eindhoven, Netherlands) at 80 kV. Images were captured with a 2Kx2K digital camera (Advanced Microscopy Techniques).
Analysis of DNA fragmentation
Cultures were rinsed three times in PBS, fixed with 4% paraformaldehyde for 10 minutes at 37
• C, rinsed, and stained with Hoechst 332584 (1 µg/ml) for 10 minutes at room temperature. The staining was visualized using a fluorescent microscope with a DAPI filter. The nuclear staining with Hoechst 332584 provided morphological discrimination between normal and apoptotic cells as described by Darzynkiewicz et al. [14] .
Results
Rodent Aβ(1-42) does not significantly affect cell viability function at 24 hours, but does so at 96 hours
Cell viability was assessed by MTT reduction is shown in Fig. 2 . Aβ(1-42) exhibited a significant decrease in cell viability compared to control at both 24 and 96 hours. However, the mean at 96 hours (75% control) was significantly different that the mean at 24 hours (56% control). Conversely, Aβ(1-42)Rat showed a decrease in MTT reduction, but was not significant following a 24 hour treatment. However, following a 96 hour treatment of neurons both peptides induced a significant decrease in MTT reduction compared to control (p < 0.02).
Aβ(1-42)Rat induces protein oxidation and lipid peroxidation in neurons
Treatment of neurons with rodent Aβ [Aβ(1-42)Rat] for 24 hours resulted in a significant increase in both protein carbonyl (Fig. 3) and HNE (Fig. 4) immunoreactivity similar to that of human Aβ (1-42) . The increase in protein oxidation induced by Aβ(1-42)Rat was to a lesser extent than that Aβ (1-42) ; however, HNE immunoreactivity induced by Aβ(1-42)Rat was similar to that induced by Aβ (1-42) . The increase in protein oxidation and lipid peroxidation was inhibited by pretreatment of the neuronal cell cultures with 50 µM vitamin E, a lipid-soluble free radical scavenger.
Rodent Aβ(1-42) is inefficient in Cu(II) reduction
Due to the hypothesis that Cu(II) is involved in the mechanism of Aβ(1-42)-mediated oxidative stress and neurotoxicity, the ability of the peptides to reduce Cu(II) was evaluated (Fig. 5) . Aβ(1-42) was able to reduce Cu(II) to 40.3% of the vitamin C control. Conversely, Aβ(1-42)Rat was able to reduce Cu(II) only 11% of the vitamin C control. These results confirm the amino acid mutations associated with the rodent sequence of Aβ(1-42) do affect the copper reduction properties of the native peptide.
Rodent Aβ(1-42) forms fibrils to a lesser extent than Aβ(1-42)
Thioflavin T binding is a measure of β-sheet formation and consequently an indication of fibril formation (Fig. 6 ). Aβ(1-42) demonstrated a concentration dependent increase in β-sheet formation with respect to increasing peptide concentration. Aβ Rat also demonstrated a concentration dependent increase in β-sheet formation with respect to increasing peptide concentration, albeit to a lesser extent. These results were confirmed by transmission electron microscopy studies (Fig. 7) , which show the extensive fibril formation of Aβ(1-42) and the lesser fibril formation of Aβ(1-42)Rat.
Rodent Aβ(1-42) results in loss of neuronal network and apoptosis in neurons
Morphological studies of the neurons were conducted following 24 hour treatment with peptides by phase contrast microscopy (Fig. 8) . Aβ(1-42) treatment resulted in loss of intact neuronal connections and dying cells. Aβ(1-42)Rat resulted in similar effects, including loss of neuronal connections and intact nerve cell bodies. These results were confirmed by Hoechst staining (Fig. 9) , which revealed apoptotic neurons in cultures treated with Aβ(1-42) or Aβ(1-42)Rat.
Discussion
Oxidative stress is the imbalance between prooxidants and antioxidant in the biological system and is associated with a number of neurodegenerative diseases including Alzheimer's disease [8] , Parkinson's disease [25] , Huntington's disease [4] , and amyotrophic lateral sclerosis [34] . Oxidative stress involves oxida- tive damage to protein, lipids, and DNA. Protein oxidation is indexed by measure of a variety of markers, including protein carbonyl and 3-nitrotyrosine (3-NT) immunoreacitivity [9] . Measures of lipid peroxidation include thiobarbituric acid reactive species (TBARS), malondialdehyde (MDA), isoprostanes, and HNE [8, 17, 47] . Oxidative stress has been shown to lead to increase protein aggregation, decreased protein turnover, loss of protein function, altered protein synthesis, altered cellular redox potential, and ultimately, cell death. Oxidative stress and lipid peroxidation are extensive in Alzheimer's disease [8, 10, 21, 30, 44, 46] . Human Aβ(1-42) is toxic to neurons in vitro and induces significant increase in protein oxidation and lipid peroxidation in neurons [51] and in vivo [15, 51] . These effects are completely inhibited by pretreatment of neurons with the free radical chain-breaking antioxidant vitamin E [3, 50] . In this study, the oxidative stress and neurotoxic properties of the rodent sequence of Aβ(1-42), Aβ(1-42)Rat, were evaluated in comparison to the human sequence of Aβ .
Aβ(1-42) was shown to induce a significant decrease in cell viability as measured by MTT reduction at both 24 and 96 hours. However, at 96 hours the mean was significantly different from that at 24 hours. This could be due to turnover of dehydrogenases in the neurons as well as upregulation of antioxidant factors in response to exposure of Aβ(1-42) such as heat shock proteins [12] . Additionally, DNA fragmentation and loss of the neurite network were found in neurons treated with Aβ . Neuronal cell cultures exposed for 24 hours to Aβ(1-42) resulted in a significant increase in both protein carbonyls and lipid peroxidation. These effects were attenuated by pretreatment of neurons with 50 µM vitamin E, confirming that ROS play a role in Aβ(1-42) mediated oxidative stress and neurotoxicity [50] . While Aβ(1-42)Rat did not show a significant decrease in cell viability at 24 hours incubation,prolonged incubation led to altered cell viability. In contrast, DNA fragmentation and loss of the neurite network in neurons were found following a 24 hour incubation time with Aβ(1-42)Rat. Additionally, Aβ(1-42)Rat induced a significant increase in neuronal protein oxidation and lipid peroxidation following a 24 hour treatment. It has been suggested that due to the amino acid variations in the rodent Aβ(1-42) sequence compared to human Aβ(1-42), rodent Aβ(1-42) is unable to form deposits in the brain [28] . However, in this study, we have shown that Aβ(1-42)Rat forms fibrils in vitro and shows a concentration dependent increase in thioflavin T binding, albeit to a lesser extent than human Aβ(1-42). Additionally, we found that Aβ(1-42)Rat resulted in a significant increase in protein oxidation and lipid peroxidation in cultures following a 24 hour treatment. This finding suggests the possible involvement of soluble aggregates of Aβ(1-42)Rat as a toxic species as it has been shown that fibril formation does not correlate with Aβ peptide-induced oxidative stress and neurotoxicity [51] . This is consistent with the notion of oxidative stress associated with soluble aggregates of human Aβ(1-42), confirmed in a study by Drake et al. [14] in which it was shown that the increase in protein oxidation in C. elegans expressing human Aβ(1-42) preceeds the deposition of Aβ . Additionally, due to the specific locations of the amino acid variations, it has been suggested that rodent Aβ(1-42) lacks the ability to bind and reduce copper. Indeed, Aβ(1-42)Rat was inefficient at reducing copper compared to human Aβ . However, these amino acid substitutions were not sufficient to prevent the oxidative damage, DNA fragmentation, and neurite disruption caused by Aβ(1-42)Rat, which were inhibited by pretreatment of the cell cultures with vitamin E. This study is particularly notable because we have shown that the rodent variation of Aβ(1-42) does form fibrils and does induce protein oxidation and lipid peroxidation in vitro. Previously, the rodent variant of human Aβ(1-42) has been thought to be non-toxic. This convention is based on the lack of fibrillar, aggregate deposits in rodent brain and the lack of ability of the rodent peptide to reduce Cu(II) to Cu(I). Nevertheless, in this study, Aβ(1-42) Rat resulted in a significant increase in both protein oxidation and lipid peroxidation, both of which contribute to the extensive oxidative stress found in AD. Additionally, further attention should be given to Aβ(1-42)Rat due to the implications of this study on the hypothesis that Cu(II) binding and reduction by human Aβ(1-42) is responsible for the oxidative stress and neurotoxicity induced by the peptide. Futhermore, the implications of this study on the therapeutic interventions based on the Cu(II) binding and reduction hypothesis should also be considered. The rodent variant of Aβ(1-42), which contains mutations of amino acids within the copper binding domain and was inefficient at reducing Cu(II) to Cu(I), demonstrated oxidative stress properties similar to that of Aβ(1-42), albeit to a lesser extent. These results suggest that Cu(II) reduction may not play a primary role in Aβ(1-42)-mediated oxidative stress and neurotoxicity, but rather the presence of methionine at residue 35 of both peptides suggests that methionine may play a more pivotal role in Aβ(1-42)-mediated oxidative stress and neurotoxicity [6, 26] .
Rodent Aβ(1-42) has been shown to accumulate in SAMP8 mice, a model of accelerated aging [29] . SAMP8 mice have been shown to spontaneously overexpress AβPP during aging, and levels of rodent Aβ have been shown to increase by ∼50% from 4 months to 12 months of age coinciding with the onset of learning and memory deficits [19, 29, 35] . Additionally, 12 month old SAMP8 mice have been shown to have increased protein oxidation and lipid peroxidation compared to 4 month old SAMP8 mice, effects that were reversed by daily injections of the antioxidant lipoic acid for four weeks [18] . Moreover, learning and memory deficits and oxidative stress at 12 months precedes granular deposition of rodent Aβ , which occurs at 16 months [29] . This finding supports the role of small, soluble aggregated rodent Aβ(1-42) as a toxic species which may contribute to the accelerated aging of SAMP8 mice. Further, administration of phosphorothiolate antisense oligonucleotide directed against the Aβ region of AβPP has been shown to decrease Aβ(1-42) levels in SAMP8 mice and protect aged SAMP8 mouse brain against oxidative stress [41] and learning and memory deficits [1, 2, 29] . Taken together, the findings associated with the role of rodent Aβ(1-42) in SAMP8 mice support our findings that rodent Aβ(1-42) induces oxidative stress and neurotoxicity similar to human Aβ(1-42), albeit to a lesser extent.
In summary, Aβ(1-42)Rat contains mutations of amino acids believed to play a role in Cu(II) binding and reduction in the human peptide and, consequently, is inefficient at reducing Cu(II) to Cu(I) compared to the vitamin C control and the human Aβ(1-42) peptide. As a result, Aβ(1-42)Rat has been presumed to be non-toxic. However, in this study we have shown that Aβ(1-42)Rat does result in significant increased DNA fragmentation and loss of neuritic network, but no loss in cell viability in a 24 hour treatment. However, cell viability was compromised by both Aβ and Aβ(1-42) Rat following a 96 hour treatment. Furthermore, treatment of neurons with Aβ(1-42)Rat for 24 hours resulted in a significant increase in protein oxidation and lipid peroxidation similar to that induced by Aβ (1-42) . These effects were inhibited by pretreatment of the neurons with the lipid-soluble free radial chain-breaking antioxidant vitamin E, suggesting that ROS play a role in the oxidative stress induced by Aβ(1-42)Rat similar to the findings with human Aβ . These results suggest that although the amino acid mutations of the rodent Aβ(1-42) peptide occur within the Cu(II) binding and reduction domain of the human peptide, these mutations were not sufficient to prevent the oxidative damage and morphological alterations induced by Aβ(1-42)Rat. Taken together, these results suggest that Cu(II) may not play a primary role in Aβ(1-42)-mediated oxidative stress and neurotoxicity, but rather a secondary role to the presence of methionine 35.
